Top

Published in:

Open Access 01-12-2024 | Underweight | Research

Association of temporal change in body mass index with sudden cardiac arrest in diabetes mellitus

Authors: Joo Hee Jeong, Yun Gi Kim, Kyung-Do Han, Seung-Young Roh, Hyoung Seok Lee, Yun Young Choi, Jaemin Shim, Jong-Il Choi, Young-Hoon Kim

Published in: Cardiovascular Diabetology | Issue 1/2024

Abstract

Background

Underweight imposes significant burden on cardiovascular outcomes in patients with diabetes mellitus. However, less is known about the impact of serial change in body weight status measured as body mass index (BMI) on the risk of sudden cardiac arrest (SCA). This study investigated the association between SCA and temporal change in BMI among patients with diabetes mellitus.

Methods

Based on Korean National Health Insurance Service database, participants with diabetes mellitus who underwent health examination between 2009 and 2012 and had prior health examination data (four years ago, 2005–2008) were retrospectively analyzed. BMI was measured at baseline (2005–2008) and 4-year follow-up health examination (2009–2012). Patients were classified in four groups according to the body weight status and its temporal change: sustained non-underweight, sustained underweight, previous underweight, and newly developed underweight. Primary outcome was defined as occurrence of SCA.

Results

A total of 1,355,746 patients with diabetes mellitus were included for analysis, and SCA occurred in 12,554 cases. SCA was most common in newly developed underweight (incidence rate = 4.45 per 1,000 person-years), followed by sustained underweight (incidence rate = 3.90), previous underweight (incidence rate = 3.03), and sustained non-underweight (incidence rate = 1.34). Adjustment of covariates resulted highest risk of SCA in sustained underweight (adjusted hazard ratio = 2.60, 95% confidence interval [2.25–3.00], sustained non-underweight as a reference), followed by newly developed underweight (2.42, [2.15–2.74]), and previous underweight (2.12, [1.77–2.53]).

Conclusions

In diabetes mellitus, sustained underweight as well as decrease in body weight during 4-year follow-up imposes substantial risk on SCA. Recovery from underweight over time had relatively lower, but yet increased risk of SCA. Both underweight and dynamic decrease in BMI can be associated with increased risk of SCA.

Available only for authorised users

Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341:1097–105. https://doi.org/10.1056/NEJM199910073411501.CrossRefPubMed

Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, van der Schouw YT, Spencer E, Moons KG, Tjonneland A, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008;359:2105–20. https://doi.org/10.1056/NEJMoa0801891.CrossRefPubMed

Seidell JC, Verschuren WM, van Leer EM, Kromhout D. Overweight, underweight, and mortality. A prospective study of 48,287 men and women. Arch Intern Med. 1996;156:958–63. https://doi.org/10.1001/archinte.156.9.958.CrossRefPubMed

Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 2007;298:2028–37. https://doi.org/10.1001/jama.298.17.2028.CrossRefPubMed

Kim YG, Han KD, Roh SY, Jeong JH, Choi YY, Min K, Shim J, Choi JI, Kim YH. Being underweight is Associated with increased risk of Sudden Cardiac Death in people with Diabetes Mellitus. J Clin Med. 2023;12. https://doi.org/10.3390/jcm12031045.

Bucholz EM, Krumholz HA, Krumholz HM, Underweight. Markers of Cachexia, and Mortality in Acute myocardial infarction: a prospective cohort study of Elderly Medicare beneficiaries. PLoS Med. 2016;13:e1001998. https://doi.org/10.1371/journal.pmed.1001998.CrossRefPubMedPubMedCentral

Hsu JC, Varosy PD, Bao H, Wang Y, Curtis JP, Marcus GM. Low body mass index but not obesity is associated with in-hospital adverse events and mortality among implantable cardioverter-defibrillator recipients: insights from the National Cardiovascular Data Registry. J Am Heart Assoc. 2012;1:e003863. https://doi.org/10.1161/JAHA.112.003863.CrossRefPubMedPubMedCentral

Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Back M, Benetos A, Biffi A, Boavida JM, Capodanno D, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227–337. https://doi.org/10.1093/eurheartj/ehab484.CrossRefPubMed

Kim YG, Roh SY, Han KD, Jeong JH, Choi YY, Min K, Shim J, Choi JI, Kim YH. Hypertension and diabetes including their earlier stage are associated with increased risk of sudden cardiac arrest. Sci Rep-Uk. 2022;12.: ARTN 12307 https://doi.org/10.1038/s41598-022-16543-2.

10.

Weidner K, Behnes M, Schupp T, Rusnak J, Reiser L, Bollow A, Taton G, Reichelt T, Ellguth D, Engelke N et al. Type 2 diabetes is independently associated with all-cause mortality secondary to ventricular tachyarrhythmias. Cardiovascular Diabetology. 2018;17. ARTN 125 https://doi.org/10.1186/s12933-018-0768-y.

11.

Jouven X, Lemaitre RN, Rea TD, Sotoodehnia N, Empana JP, Siscovick DS. Diabetes, glucose level, and risk of sudden cardiac death. Eur Heart J. 2005;26:2142–7. https://doi.org/10.1093/eurheartj/ehi376.CrossRefPubMed

12.

Jouven X, Desnos M, Guerot C, Ducimetiere P. Predicting sudden death in the population: the Paris prospective study I. Circulation. 1999;99:1978–83. https://doi.org/10.1161/01.cir.99.15.1978.CrossRefPubMed

13.

Xu LJ, Li DZ. Body-weight fluctuations and outcomes in Coronary Disease. N Engl J Med. 2017;377:94–4.CrossRefPubMed

14.

Ferrannini G, Pollock C, Natali A, Yavin Y, Mahaffey KW, Ferrannini E. Extremes of both weight gain and weight loss are associated with increased incidence of heart failure and cardiovascular death: evidence from the CANVAS Program and CREDENCE. Cardiovasc Diabetol. 2023;22. ARTN 100. https://doi.org/10.1186/s12933-023-01832-5

15.

Song SO, Jung CH, Song YD, Park CY, Kwon HS, Cha BS, Park JY, Lee KU, Ko KS, Lee BW. Background and data configuration process of a nationwide population-based study using the Korean national health insurance system. Diabetes Metab J. 2014;38:395–403. https://doi.org/10.4093/dmj.2014.38.5.395.CrossRefPubMedPubMedCentral

16.

Lee J, Lee JS, Park SH, Shin SA, Kim K. Cohort Profile: the National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol. 2017;46:e15. https://doi.org/10.1093/ije/dyv319.CrossRefPubMed

17.

Kim YG, Han K, Jeong JH, Roh SY, Choi YY, Min K, Shim J, Choi JI, Kim YH. Metabolic syndrome, Gamma-Glutamyl Transferase, and risk of Sudden Cardiac Death. J Clin Med. 2022;11. https://doi.org/10.3390/jcm11071781.

18.

Kim YG, Han KD, Choi JI, Choi YY, Choi HY, Boo KY, Kim DY, Lee KN, Shim J, Kim JS, et al. Non-genetic risk factors for atrial fibrillation are equally important in both young and old age: a nationwide population-based study. Eur J Prev Cardiol. 2021;28:666–76. https://doi.org/10.1177/2047487320915664.CrossRefPubMed

19.

Kim YG, Han KD, Choi JI, Yung Boo K, Kim DY, Oh SK, Lee KN, Shim J, Kim JS, Kim YH. Impact of the duration and degree of hypertension and body weight on New-Onset Atrial Fibrillation: a Nationwide Population-based study. Hypertension. 2019;74:e45–e51. https://doi.org/10.1161/HYPERTENSIONAHA.119.13672.CrossRefPubMed

20.

Kim YG, Jeong JH, Han KD, Roh SY, Min KYJ, Lee HS, Choi YY, Shim J, Choi JI, Kim YH. Association between low-density lipoprotein cholesterol and sudden cardiac arrest in people with diabetes mellitus. Cardiovascular Diabetology. 2023;22. ARTN 36; https://doi.org/10.1186/s12933-023-01769-9.

21.

Mathur MB, VanderWeele TJ. Assessing Uncontrolled Confounding in Associations of Being Overweight With All-Cause Mortality. Jama Netw Open. 2022;5. ARTN e222614. https://doi.org/10.1001/jamanetworkopen.2022.2614.

22.

Kim YG, Jeong JH, Roh SY, Han KD, Choi YY, Min K, Shim J, Choi JI, Kim YH. Obesity is indirectly Associated with Sudden Cardiac arrest through various risk factors. J Clin Med. 2023;12. https://doi.org/10.3390/jcm12052068.

23.

Dahl AK, Fauth EB, Ernsth-Bravell M, Hassing LB, Ram N, Gerstof D. Body Mass Index, Change in Body Mass Index, and survival in old and very old persons. J Am Geriatr Soc. 2013;61:512–8. https://doi.org/10.1111/jgs.12158.CrossRefPubMedPubMedCentral

24.

Cheng YJ, Chen ZG, Wu SH, Mei WY, Yao FJ, Zhang M, Luo DL. Body mass index trajectories during mid to late life and risks of mortality and cardiovascular outcomes: results from four prospective cohorts. EClinicalMedicine. 2021;33:100790. https://doi.org/10.1016/j.eclinm.2021.100790.CrossRefPubMedPubMedCentral

25.

Webb JG, Kiess MC, Chan-Yan CC. Malnutrition and the heart. CMAJ. 1986;135:753–8.PubMedPubMedCentral

26.

Matinrazm S, Ladejobi A, Pasupula DK, Javed A, Durrani A, Ahmad S, Munir MB, Adelstein E, Jain SK, Saba S. Effect of body mass index on survival after sudden cardiac arrest. Clin Cardiol. 2018;41:46–50. https://doi.org/10.1002/clc.22847.CrossRefPubMedPubMedCentral

27.

Rozen G, Elbaz-Greener G, Marai I, Heist EK, Ruskin JN, Carasso S, Birati EY, Amir O. The relationship between the body mass index and in-hospital mortality in patients admitted for sudden cardiac death in the United States. Clin Cardiol. 2021;44:1673–82. https://doi.org/10.1002/clc.23730.CrossRefPubMedPubMedCentral

28.

Testori C, Sterz F, Losert H, Krizanac D, Haugk M, Uray T, Arrich J, Stratil P, Sodeck G. Cardiac arrest survivors with moderate elevated body mass index may have a better neurological outcome: a cohort study. Resuscitation. 2011;82:869–73. https://doi.org/10.1016/j.resuscitation.2011.02.027.CrossRefPubMed

Title: Association of temporal change in body mass index with sudden cardiac arrest in diabetes mellitus
Authors: Joo Hee Jeong
Yun Gi Kim
Kyung-Do Han
Seung-Young Roh
Hyoung Seok Lee
Yun Young Choi
Jaemin Shim
Jong-Il Choi
Young-Hoon Kim
Publication date: 01-12-2024
Publisher: BioMed Central
Keywords: Underweight
Underweight
Diabetes
Published in: Cardiovascular Diabetology / Issue 1/2024
Electronic ISSN: 1475-2840
DOI: https://doi.org/10.1186/s12933-024-02130-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2024

Repressive H3K27me3 drives hyperglycemia-induced oxidative and inflammatory transcriptional programs in human endothelium

Use of the energy waveform electrocardiogram to detect subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus

Systolic blood pressure status modifies the associations between the triglyceride-glucose index and incident cardiovascular disease: a national cohort study in China

Protective effects of imeglimin on the development of atherosclerosis in ApoE KO mice treated with STZ

Evaluation of the role of atherogenic index of plasma in the reversion from Prediabetes to normoglycemia or progression to Diabetes: a multi-center retrospective cohort study

The additive effect of metabolic syndrome on left ventricular impairment in patients with obstructive coronary artery disease assessed by 3.0 T cardiac magnetic resonance feature tracking

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials